Literature DB >> 19695763

Assessment of preoperative serum prolidase activity in epithelial ovarian cancer.

Hakan Camuzcuoglu1, Dagistan Tolga Arioz, Harun Toy, Sefa Kurt, Hakim Celik, Nurten Aksoy.   

Abstract

OBJECTIVE: Prolidase is a cytosolic exopeptidase that cleaves iminodipeptides with C-terminal proline and hydroxyproline and plays a major role in collagen turnover. The aim of this study was to evaluate preoperative serum prolidase activity, total oxidant status (TOS), and total antioxidant capacity (TAC) in patients with newly diagnosed epithelial ovarian cancer (EOC). STUDY
DESIGN: Serum prolidase activity, TOS, and TAC were measured spectrophotometrically in both EOC cases (n=28) and controls (n=28).
RESULTS: Preoperative serum prolidase activity and TOS were significantly higher in patients with EOC compared to controls (p=0.009 and 0.008, respectively), whereas TAC was significantly lower in cases (p<0.001). A significant positive correlation was found between the stage, grade, and CA-125 level of EOC and serum prolidase activity (rho=0.466, p=0.012; rho=0.501, p=0.007; and rho=0.447, p=0.017, respectively) and TOS (rho=0.588, p=0.001; rho=0.412, p=0.029; and rho=0.568, p=0.002, respectively). In contrast, there was a negative correlation between TAC and the stage, grade, and CA-125 level of EOC (rho=-0.555, p=0.002; rho=-0.566, p=0.002; and rho=-0.581, p=0.001, respectively).
CONCLUSION: Findings of the present study demonstrate that serum prolidase activity is significantly associated with the stage, tumor grade, and preoperative CA-125 level of EOC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19695763     DOI: 10.1016/j.ejogrb.2009.07.012

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  14 in total

1.  Serum prolidase activity in idiopathic and ischemic cardiomyopathy patients.

Authors:  Yusuf Sezen; Memduh Bas; Halil Altiparmak; Ali Yildiz; Hakan Buyukhatipoglu; Omer Faruk Dag; Zekeriya Kaya; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Relationship of hemoxygenase-1 and prolidase enzyme activity with oxidative stress in papillary thyroid cancer.

Authors:  D Terzioglu; S Teksoz; A E Arikan; E Uslu; E Yılmaz; B Eren
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

3.  The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer.

Authors:  İlhan Gecit; Recep Eryılmaz; Servet Kavak; İsmail Meral; Halit Demir; Necip Pirinççi; Mustafa Güneş; Kerem Taken
Journal:  J Membr Biol       Date:  2017-08-16       Impact factor: 1.843

4.  The relationships among the levels of oxidative and antioxidative parameters, FEV1 and prolidase activity in COPD.

Authors:  Selami Ekin; Ahmet Arısoy; Hulya Gunbatar; Bunyamin Sertogullarindan; Aysel Sunnetcioglu; Hatice Sezen; Selvi Asker; Hanifi Yıldız
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

5.  Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.

Authors:  Sevil Uygun Ilikhan; Muammer Bilici; Hatice Sahin; Ayşe Semra Demir Akca; Murat Can; Ibrahim Ilker Oz; Berrak Guven; M Cagatay Buyukuysal; Yucel Ustundag
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

6.  Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?

Authors:  Adnan Incebiyik; Mehmet Vural; Hakan Camuzcuoglu; Abdullah Taskin; Aysun Camuzcuoglu; Nese Gul Hilali; Nurten Aksoy
Journal:  Wien Klin Wochenschr       Date:  2015-04-14       Impact factor: 1.704

7.  The Value of Serum Prolidase Activity in Progression of Microalbuminuria in Patients With Type 2 Diabetes Mellitus.

Authors:  Tevfik Sabuncu; Omer Boduroglu; Mehmet Ali Eren; Ayse Nur Torun; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

8.  Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer.

Authors:  Ilhan Gecit; Mehmet Aslan; Mustafa Gunes; Necip Pirincci; Ramazan Esen; Halit Demir; Kadir Ceylan
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-19       Impact factor: 4.553

9.  Prolidase activity in chronic plaque psoriasis patients.

Authors:  Hacer Altın Sürücü; Nurten Aksoy; Orhan Ozgöztas; Hatice Sezen; Yavuz Yesilova; Enver Turan
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

10.  Serum prolidase activity, total oxidant/antioxidant, and nitric oxide levels in patients with esophageal squamous cell carcinoma.

Authors:  Fuat Sayır; Abidin Şehitoğulları; Halit Demir; Mehmet Aslan; Ufuk Çobanoğlu; Cahit Bilgin
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-04-24       Impact factor: 0.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.